The Effect of Rectus Muscle Approximation at Cesarean Delivery on Pain Perceived After Operation
1 other identifier
interventional
280
1 country
1
Brief Summary
This is a prospective randomized controlled study to determine the clinical outcome of rectus muscle re-approximation at Cesarean delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2017
CompletedFirst Posted
Study publicly available on registry
October 11, 2017
CompletedStudy Start
First participant enrolled
October 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2018
CompletedFebruary 5, 2018
February 1, 2018
3 months
October 6, 2017
February 1, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Early pain score
Early pain score will be assessed by an investigator for patients
24 hours after cesarean section
Secondary Outcomes (1)
Late pain score
48 hours after cesarean section
Study Arms (2)
Rectus muscle approximation
ACTIVE COMPARATORThree sutures will be done for the the purpose of rectus muscle approximation in cesarean section.
Control
NO INTERVENTIONNo approximation for the rectus muscle will be done for the control group in cesarean section.
Interventions
The surgeon will take sutures to approximate rectus muscles at the end of cesarean delivery.
Eligibility Criteria
You may qualify if:
- Women who will undergo first elective cesarean section
- Singleton pregnancy
You may not qualify if:
- Previous abdominal or pelvic surgery
- Medical or psychiatric disease
- Previous pelvic inflammatory disease
- Obesity
- Allergy to analgesics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Department of Obstetrics and Gynecology, Kasr Al-Ainy hospital
Cairo, Greater Cairo, 11956, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eman F Omran, M.D.
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
October 6, 2017
First Posted
October 11, 2017
Study Start
October 11, 2017
Primary Completion
January 15, 2018
Study Completion
January 20, 2018
Last Updated
February 5, 2018
Record last verified: 2018-02